TALAZOPARIB for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 125 adverse event reports in the FDA FAERS database where TALAZOPARIB was used for Prostate cancer.
Most Reported Side Effects for TALAZOPARIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Anaemia | 219 | 14.8% | 20 | 80 |
| Neoplasm progression | 169 | 11.4% | 54 | 37 |
| Death | 142 | 9.6% | 142 | 9 |
| Off label use | 78 | 5.3% | 16 | 13 |
| Thrombocytopenia | 78 | 5.3% | 17 | 33 |
| Fatigue | 77 | 5.2% | 5 | 17 |
| Platelet count decreased | 68 | 4.6% | 8 | 30 |
| Haemoglobin decreased | 65 | 4.4% | 1 | 24 |
| Febrile neutropenia | 60 | 4.1% | 9 | 52 |
| Pancytopenia | 60 | 4.1% | 7 | 24 |
| Nausea | 53 | 3.6% | 3 | 17 |
| Neutropenia | 47 | 3.2% | 3 | 13 |
| Dyspnoea | 43 | 2.9% | 12 | 29 |
| Asthenia | 39 | 2.6% | 3 | 16 |
| Haematotoxicity | 38 | 2.6% | 1 | 5 |
Other Indications for TALAZOPARIB
Prostate cancer metastatic (155)
Breast cancer metastatic (146)
Breast cancer (119)
Breast cancer female (69)
Hormone-refractory prostate cancer (69)
Product used for unknown indication (61)
Neoplasm (29)
Triple negative breast cancer (26)
Neoplasm malignant (18)
Ovarian cancer (18)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)